Fig. 3From: Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trialLevels of circulating immunoglobulins. IgE (a-b) and IgG4 (c-d) were measured before treatment, four weeks after treatment and after the consecutive pollen season in patients treated with active ILIT (a, c) or placebo (b, d). Analysis was performed using a repeated measures ANOVA. ILIT: Intralymphatic immunotherapyBack to article page